Truist Securities Reiterates Microchip Technology Incorporated

Truist Securities reiterated a "Hold" recommendation for Microchip Technology Incorporated - Preferred Stock (MCHPP) on November 7, 2025, while analysts project an average one-year price target of $72.00, representing a 35.51% upside from its $53.13 closing price and a projected non-GAAP EPS of $1.27. Institutional sentiment for MCHPP is notably positive, with the number of funds holding positions increasing by 12.20% and total institutional shares rising 7.70% to 53,445K in the last quarter, indicating growing investor interest despite the neutral analyst rating.

Analysis

Truist Securities reiterated a "Hold" recommendation for Microchip Technology Incorporated - Preferred Stock (MCHPP) on November 7, 2025. Despite this neutral rating, the average one-year price target is $72.00/share, suggesting a significant 35.51% upside from its recent closing price of $53.13/share. This target range spans from $56.00 to $87.33, indicating a broad consensus on potential appreciation.

Institutional investor sentiment for MCHPP appears moderately positive, with a notable increase in ownership. The number of funds reporting positions rose by 12.20% (15 new owners) in the last quarter, and total institutional shares increased by 7.70% to 53,445K shares. The average portfolio weight dedicated to MCHPP also saw a substantial 38.92% increase, reflecting growing interest.

While overall institutional interest is up, there are divergent actions among major holders; Capital International Investors increased its allocation by 17.03%, whereas Voya Investment Management significantly decreased its allocation by 58.06%. The projected annual non-GAAP EPS stands at $1.27, providing a fundamental metric for valuation alongside the price targets. This mixed positioning suggests varying perspectives on the preferred stock's near-term prospects despite the implied upside.

Key Decisions for Investors

• Investors should carefully evaluate the significant implied upside of 35.51% against Truist's neutral 'Hold' rating and the projected $1.27 non-GAAP EPS.
• Monitor future institutional ownership reports for MCHPP, as current data shows divergent positioning among major funds despite an overall increase in institutional holdings.
• Consider the specific characteristics and risk profile of preferred stock investments, such as dividend stability and seniority, when assessing MCHPP's potential.